Journal of Clinical Endocrinology & Metabolism, Vol 81, 1076-1082, Copyright © 1996 by Endocrine Society

ARTICLES

Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha- pregnan-20-one

M Wang, L Seippel, RH Purdy and T Backstrom
Department of Obstetrics and Gynecology and Physiology, University of Umea, Sweden.

The relationship between symptoms of premenstrual syndrome (PMS) and serum levels of pregnenolone (Pe), pregnenolone sulfate (PS), 5 alpha- pregnane-3,20-dione (5 alpha-DHP), 3 alpha-hydroxy-5 alpha- pregnan-20- one (5 alpha-THP), LH, 17 beta-estradiol (E2), and progesterone (P) was investigated during 2 consecutive menstrual cycles in 12 patients using daily measurements. Corresponding hormones were also measured during 1 cycle in 8 control women. Pe, PS, 5 alpha-DHP, and 5 alpha-THP showed a significant cyclicity within menstrual cycles and a high rate of correlation with P variation in both PMS patients and controls. No significant difference was found between PMS patients and controls in average serum concentrations of Pe, PS, 5 alpha-DHP, 5 alpha-THP, and LH during the luteal phase, whereas a significantly higher level of E2 and a lower level of P were observed in PMS patients. The variation in symptom scores was compared with that in hormone levels within each woman. The symptom peak showed a delay of 3-4 days after the serum P, Pe, 5 alpha-DHP, and 5 alpha-THP peaks. However, the plasma PS peak appeared on the same day or only 1 day before the symptom peak in PMS patients. When comparing the 2 cycles studied, more negative symptoms occurred in cycles with higher luteal phase E2, Pe, and PS concentrations, whereas higher luteal phase 5 alpha-DHP and 5 alpha-THP concentrations were associated with improved symptom ratings in PMS patients. These results suggest that the mentioned steroids are related to the severity of distressing symptoms in PMS patients.

This article has been cited by other articles:

				S. Thys-Jacobs, D. McMahon, and J. P. Bilezikian Differences in Free Estradiol and Sex Hormone-Binding Globulin in Women with and without Premenstrual Dysphoric Disorder J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 96 - 102. [Abstract] [Full Text] [PDF]

				O. V. Belyaeva, S. V. Chetyrkin, A. L. Clark, N. V. Kostereva, K. S. SantaCruz, B. M. Chronwall, and N. Y. Kedishvili Role of Microsomal Retinol/Sterol Dehydrogenase-Like Short-Chain Dehydrogenases/Reductases in the Oxidation and Epimerization of 3{alpha}-Hydroxysteroids in Human Tissues Endocrinology, May 1, 2007; 148(5): 2148 - 2156. [Abstract] [Full Text] [PDF]

				X. Protopopescu, H. Pan, M. Altemus, O. Tuescher, M. Polanecsky, B. McEwen, D. Silbersweig, and E. Stern Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle PNAS, November 1, 2005; 102(44): 16060 - 16065. [Abstract] [Full Text] [PDF]

				J. M. Wang, P. B. Johnston, B. G. Ball, and R. D. Brinton The Neurosteroid Allopregnanolone Promotes Proliferation of Rodent and Human Neural Progenitor Cells and Regulates Cell-Cycle Gene and Protein Expression J. Neurosci., May 11, 2005; 25(19): 4706 - 4718. [Abstract] [Full Text] [PDF]

				K. Pazol, M. E. Wilson, and K. Wallen Medroxyprogesterone Acetate Antagonizes the Effects of Estrogen Treatment on Social and Sexual Behavior in Female Macaques J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2998 - 3006. [Abstract] [Full Text] [PDF]

				M. Gulinello and S. S. Smith Anxiogenic Effects of Neurosteroid Exposure: Sex Differences and Altered GABAA Receptor Pharmacology in Adult Rats J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 541 - 548. [Abstract] [Full Text] [PDF]

				A. Strohle, E. Romeo, F. di Michele, A. Pasini, B. Hermann, G. Gajewsky, F. Holsboer, and R. Rupprecht Induced Panic Attacks Shift {gamma}-Aminobutyric Acid Type A Receptor Modulatory Neuroactive Steroid Composition in Patients With Panic Disorder: Preliminary Results Arch Gen Psychiatry, February 1, 2003; 60(2): 161 - 168. [Abstract] [Full Text] [PDF]

				C. N. Epperson, K. Haga, G. F. Mason, E. Sellers, R. Gueorguieva, W. Zhang, E. Weiss, D. L. Rothman, and J. H. Krystal Cortical {gamma}-Aminobutyric Acid Levels Across the Menstrual Cycle in Healthy Women and Those With Premenstrual Dysphoric Disorder: A Proton Magnetic Resonance Spectroscopy Study Arch Gen Psychiatry, September 1, 2002; 59(9): 851 - 858. [Abstract] [Full Text] [PDF]

				P. Follesa, M. Serra, E. Cagetti, M. G. Pisu, S. Porta, S. Floris, F. Massa, E. Sanna, and G. Biggio Allopregnanolone Synthesis in Cerebellar Granule Cells: Roles in Regulation of GABAA Receptor Expression and Function during Progesterone Treatment and Withdrawal Mol. Pharmacol., June 1, 2000; 57(6): 1262 - 1270. [Abstract] [Full Text]

				L. D. Griffin and S. H. Mellon Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes PNAS, November 9, 1999; 96(23): 13512 - 13517. [Abstract] [Full Text] [PDF]

				C. N. Epperson, K. L. Wisner, and B. Yamamoto Gonadal Steroids in the Treatment of Mood Disorders Psychosom Med, September 1, 1999; 61(5): 676 - 697. [Abstract] [Full Text] [PDF]

				A. Concas, M. C. Mostallino, P. Porcu, P. Follesa, M. L. Barbaccia, M. Trabucchi, R. H. Purdy, P. Grisenti, and G. Biggio Role of brain allopregnanolone in the plasticity of gamma -aminobutyric acid type A receptor in rat brain during pregnancy and after delivery PNAS, October 27, 1998; 95(22): 13284 - 13289. [Abstract] [Full Text] [PDF]

				J. C. Prior Perimenopause: The Complex Endocrinology of the Menopausal Transition Endocr. Rev., August 1, 1998; 19(4): 397 - 428. [Abstract] [Full Text] [PDF]

				E. Romeo, A. Ströhle, G. Spalletta, F. d. Michele, B. Hermann, F. Holsboer, A. Pasini, and R. Rupprecht Effects of Antidepressant Treatment on Neuroactive Steroids in Major Depression Am J Psychiatry, July 1, 1998; 155(7): 910 - 913. [Abstract] [Full Text]

				L. Seippel and T. Bäckström Luteal-Phase Estradiol Relates to Symptom Severity in Patients with Premenstrual Syndrome J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1988 - 1992. [Abstract] [Full Text]

				A. R. Genazzani, F. Petraglia, F. Bernardi, E. Casarosa, C. Salvestroni, A. Tonetti, R. E. Nappi, S. Luisi, M. Palumbo, R. H. Purdy, et al. Circulating Levels of Allopregnanolone in Humans: Gender, Age, and Endocrine Influences J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2099 - 2103. [Abstract] [Full Text]

				V. Uzunova, Y. Sheline, J. M. Davis, A. Rasmusson, D. P. Uzunov, E. Costa, and A. Guidotti Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine PNAS, March 17, 1998; 95(6): 3239 - 3244. [Abstract] [Full Text] [PDF]

				P. J. Schmidt, L. K. Nieman, M. A. Danaceau, L. F. Adams, and D. R. Rubinow Differential Behavioral Effects of Gonadal Steroids in Women with and in Those without Premenstrual Syndrome N. Engl. J. Med., January 22, 1998; 338(4): 209 - 216. [Abstract] [Full Text] [PDF]